Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China · Delayed Price · Currency is CNY 48.16
-1.15 (-2.33%)
Aug 1, 2025, 2:45 PM CST
Jiangsu Sinopep-Allsino Biopharmaceutical Company Description
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
The company offers APIs, including peptides, small molecules, and oligonucleotides; and intermediate products, such as fulvestrant, oseltamivir, and other intermediates.
It also provides CRDMO/CMO services. The company was founded in 2009 and is headquartered in Hangzhou City, China.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
| Country | China |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,028 |
| CEO | Ziquan Tong |
Contact Details
Address: Building E Hangzhou City, 311121 China | |
| Phone | 86 571 8867 1216 |
| Website | sinopep.com |
Stock Details
| Ticker Symbol | 688076 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000051X5 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ziquan Tong | GM and Chairman |
| Wei Ding | Financial Director |
| Xiaohua Li | Senior Vice President |
| Guoqiang Shi | Senior Vice President and Director |
| Zhou Hua | Secretary of Board |
| Dr. Jianjun Jiang Ph.D. | Vice President |
| Yanwen Chen | Accounting Supervisor |